Poliorix™

BIOLOGICAL4 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHepatitis BPoliomyelitisPoliomyelitis VaccinesTetanusWhole Cell Pertussis

Phase 2

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

CompletedNCT01106092

GlaxoSmithKlineDiphtheria, Haemophilus Influenzae Type b, Hepatitis B +3

Start: 2010-05-13End: 2010-09-02Updated: 2019-10-01

Phase 3

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine

CompletedNCT01021293

GlaxoSmithKlinePoliomyelitis, Poliomyelitis Vaccines

Start: 2009-11-28End: 2010-07-05Updated: 2020-01-21

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

CompletedNCT01086423

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +2

Start: 2010-03-01End: 2010-11-19Updated: 2018-06-06

Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

CompletedNCT01449812

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +1

Start: 2011-10-01End: 2012-01-16Updated: 2018-06-06

Related Papers

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and<i>Haemophilus influenzae</i>type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants

Human Vaccines & Immunotherapeutics2016-10-2116 citations

Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.

2016-02-0911 citations

A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers.

2012-02-149 citations